FDA Approves Pfizer and Moderna COVID-19 Vaccines for Emerging KP.2 Variant in Tri-State Area
The FDA approved new COVID-19 vaccines targeting the KP.2 variant, with distribution in the Tri-State area imminent. These shots aim to offer better protection against this strain, particularly severe outcomes.
Latest News
Aug 23, 2024
FDA Approves Pfizer and Moderna COVID-19 Vaccines for Emerging KP.2 Variant in Tri-State Area
Aug 19, 2024
Outbreak of Cryptosporidium Linked to Erlanger Water Park, Northern Kentucky Health Officials Warn
Jan 31, 2020
Jan 23, 2020